Related Experiment Video
Updated: Jul 9, 2025
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
133
Role of IFN-α in Rheumatoid Arthritis
Chung M A Lin1,2, John D Isaacs1,2, Faye A H Cooles3,4
1Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Current Rheumatology Reports
|December 5, 2023
Summary
Type 1 interferons (IFN-I) play a role in rheumatoid arthritis (RA) pathophysiology. Further research is needed to understand IFN-I biology and develop targeted therapies for RA.
Area of Science:
- Immunology
- Rheumatology
- Autoimmune Diseases
Background:
- Type 1 interferons (IFN-I) are gaining attention in autoimmune rheumatic diseases.
- Research on IFN-I's role in rheumatoid arthritis (RA) has historically been limited but is now increasing.
- Recent findings suggest a potential contribution of IFN-I to RA pathophysiology.
Purpose of the Study:
- To review the role of IFN-I in RA, considering disease stage.
- To explore the direct cellular functions influenced by IFN-I in RA.
- To examine the impact of IFN-I signaling on clinical trajectory and genetic risk factors.
Main Methods:
- Literature review focusing on recent advancements in IFN-I research in RA.
- Analysis of cellular functions affected by IFN-I.
- Exploration of environmental triggers and genetic risk factors associated with IFN-I signaling.
Main Results:
- IFN-I signaling influences various cellular functions relevant to RA.
- Clinical trajectory in RA may be affected by increased IFN-I signaling.
- Potential links between IFN-I exposure, epigenetic changes, and RA processes are identified.
Conclusions:
- IFN-I likely plays a role in RA pathogenesis.
- Knowledge gaps exist regarding IFN-I biology in RA, especially in at-risk populations.
- Future research should focus on understanding IFN-I biology and developing targeted therapeutic strategies for RA.
Keywords:
BiomarkersEarly rheumatoid arthritisInterferon gene signatureRheumatoid arthritisType 1 interferonsMore Related Videos
Related Concept Videos
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
143
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
143
02:26NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:28Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
168
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
168